X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/16/2864172/0/en/Nurix-Therapeutics-Announces-Closing-of-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
https://www.globenewswire.com/news-release/2024/04/12/2861966/0/en/Nurix-Therapeutics-Announces-Pricing-of-Upsized-175-0-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/04/11/2861854/0/en/Nurix-Therapeutics-Announces-Proposed-Public-Offering.html
https://www.globenewswire.com/news-release/2024/04/10/2860611/0/en/Nurix-Therapeutics-Reports-First-Quarter-Fiscal-2024-Financial-Results-and-Provides-a-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/09/2860287/0/en/Nurix-Therapeutics-Reports-First-Clinical-Evidence-of-CNS-Activity-of-NX-5948-a-Brain-Penetrant-Orally-Available-BTK-Degrader-in-Development-for-B-Cell-Malignancies.html
https://www.globenewswire.com/news-release/2024/04/09/2859831/0/en/Nurix-Therapeutics-Announces-Extension-of-Strategic-Collaboration-with-Sanofi-to-Develop-Novel-Targeted-Protein-Degraders-of-STAT6.html
https://www.globenewswire.com/news-release/2024/04/03/2856786/0/en/Nurix-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.fiercebiotech.com/biotech/gilead-dives-deeper-nurix-protein-degrader-collab-paying-15m-2-year-extension
https://www.globenewswire.com/news-release/2024/03/25/2851486/0/en/Nurix-Therapeutics-is-Part-of-a-Team-of-International-Oncology-Experts-Selected-as-Cancer-Grand-Challenges-Awardees-to-Address-Pediatric-Cancers-Using-Targeted-Protein-Degradation-.html
Market Place
Share 
